{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:06:45Z","timestamp":1780333605815,"version":"3.54.1"},"reference-count":123,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["accp1.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nonsteroidal anti\u2010inflammatory drugs (NSAIDs) are commonly used for the management of fever, pain, and inflammation. However, they have always been considered to have a double\u2010faced role, according to their capacity to manage inflammation but also their possible reduction of immune system response and diagnosis delay. This last point could favor a dramatic increase of viral infection diffusion, possibly leading to a more severe outcome. The advent of severe acute respiratory syndrome coronavirus 2 excluded the use of NSAIDs, particularly ibuprofen, and then indicated this drug as the better NSAID to manage infected outpatients and prevent complications. Several authors described the role of NSAIDs and ibuprofen in preventing cytokine storm and modulating the immune system. However, the development of both adverse drug reactions (i.e., gastrointestinal, renal, hepatic, and cardiovascular) and drug interaction recalled the necessity of prescribing the better NSAID for each patient. In this narrative review, we describe the role of NSAIDs, particularly of ibuprofen, in the management of viral symptoms, suggesting that the NSAID may be chosen considering the characteristics of the patient, the comorbidity, and the polytherapy.<\/jats:p>","DOI":"10.1002\/jcph.2258","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T05:56:27Z","timestamp":1682920587000},"page":"975-992","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ibuprofen in the Management of Viral Infections: The Lesson of COVID\u201019 for Its Use in a Clinical Setting"],"prefix":"10.1002","volume":"63","author":[{"given":"Gianmarco","family":"Marcian\u00f2","sequence":"first","affiliation":[{"name":"Operative Unit of Pharmacology and Pharmacovigilance, \u201cMater Domini\u201d Hospital, Department of Health Science University Magna Graecia  Catanzaro Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0858-7902","authenticated-orcid":false,"given":"Lucia","family":"Muraca","sequence":"additional","affiliation":[{"name":"Department of Primary Care  Catanzaro Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Rania","sequence":"additional","affiliation":[{"name":"Operative Unit of Pharmacology and Pharmacovigilance, \u201cMater Domini\u201d Hospital, Department of Health Science University Magna Graecia  Catanzaro Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gallelli","sequence":"additional","affiliation":[{"name":"Operative Unit of Pharmacology and Pharmacovigilance, \u201cMater Domini\u201d Hospital, Department of Health Science University Magna Graecia  Catanzaro Italy"},{"name":"Department of Primary Care  Catanzaro Italy"},{"name":"Research Center FAS@UMG Department of Health Science University Magna Graecia  Catanzaro Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"GhlichlooI GerrietsV.Nonsteroidal Anti\u2010Inflammatory Drugs.StatPearls. Published 2022. Accessed2022.https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547742\/?report=printable"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.4.449"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104849"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2009.03.007"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.05.025"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2012.02.003"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101373"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600\u20100773.1997.tb00291.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742\u20102094\u20108\u2010102"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.22034\/iji.2022.93951.2267"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787\u2010020\u201000745\u2010z"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.04.015"},{"issue":"5","key":"e_1_2_8_14_1","first-page":"379","article-title":"Action of non\u2010steroidal anti\u2010inflammatory agents on the immune system","volume":"58","author":"Cortet B","year":"1991","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620\u2010006\u20108045\u20104"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169\u2010328X(97)00168\u2010X"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.30491\/IJMR.2021.275730.1193"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1163\/156856003322699627"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006\u20102952(84)90228\u20104"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12446"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152913"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01018\u201018"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2000.0562"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1086\/590499"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2014.979230"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.04.053"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940\u20106207.CAPR\u201011\u20100496"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0810740105"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/02713680802650377"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022\u20101317\u201083\u20108\u20101897"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/135965350601100803"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/194589240101500404"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1086\/341455"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/app11167457"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1086"},{"key":"e_1_2_8_36_1","unstructured":"HealthC.France says ibuprofen may aggravate coronavirus. Experts say more evidence is needed. Published 2020. Accessed2022.https:\/\/edition.cnn.com\/2020\/03\/16\/health\/coronavirus\u2010ibuprofen\u2010french\u2010health\u2010minister\u2010scn\u2010intl\u2010scli\/index.html"},{"key":"e_1_2_8_37_1","unstructured":"MelvilleNA NainggolanL.Are warnings against NSAIDs in COVID\u201019 warranted? Medscape. Published 2020. Accessed 2022.https:\/\/www.medscape.com\/viewarticle\/926940"},{"key":"e_1_2_8_38_1","unstructured":"AIFA.ComunicazioneEMA sull'uso di anti\u2010infiammatori non steroidei per COVID\u201019. Published 2020. Accessed2022.https:\/\/www.aifa.gov.it\/\u2010\/comunicazione\u2010ema\u2010sull\u2010uso\u2010di\u2010anti\u2010infiammatori\u2010non\u2010steroidei\u2010per\u2010covid\u201019"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665\u20109913(21)00104\u20101"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.06.003"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/v12101092"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787\u2010022\u201001029\u20104"},{"key":"e_1_2_8_43_1","unstructured":"Canadian Pharmacists Association.Use of NSAIDs in patients with COVID\u201019: what is the evidence?Published 2020. Accessed2022.https:\/\/www.pharmacists.ca\/cpha\u2010ca\/assets\/File\/cpha\u2010on\u2010the\u2010issues\/Use\u2010of\u2010NSAIDs\u2010in\u2010patients\u2010with\u2010COVID\u201019\u2010FINAL\u2010EN.pdf"},{"key":"e_1_2_8_44_1","unstructured":"PHO.Public health Ontario use of non\u2010steroidal anti\u2010inflammatory drugs and COVID\u201019. Published 2020. Accessed2022.https:\/\/www.publichealthontario.ca\/\u2010\/media\/documents\/ncov\/covid\u2010wwksf\/what\u2010we\u2010know\u2010nsaids.pdf"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00014\u201021"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.12.001"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.371"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113932"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa449"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00215.2020"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102184.2008.00538.x"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/JCP"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010020\u20101051\u20109"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2013.06.026"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.03.007"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118743614"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985\u2010022\u201001813\u20102"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S247781"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102014\u2010206914"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.19315"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011\u2010200727020\u201000004"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266\u2010019\u201000660\u20101"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296\u2010011\u20102263\u20106"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325\u2010019\u201001144\u20109"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906\u2010022\u201001205\u20105"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001098"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1302"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr\u20102014\u2010205237"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2345"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060786"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00225"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2020.1744563"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1515\/aiht\u20102016\u201067\u20102754"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.12.003"},{"issue":"7","key":"e_1_2_8_76_1","first-page":"601","article-title":"Pharmacokinetic drug\u2010drug interaction and their implication in clinical management","volume":"18","author":"Palleria C","year":"2013","journal-title":"J Res Med Sci"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102362.2009.02153.x"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1267"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03712"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1736644"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00594172"},{"key":"e_1_2_8_82_1","unstructured":"National Institutes of Health.Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID\u201019). NIH. Published 2022. Accessed2022.https:\/\/www.covid19treatmentguidelines.nih.gov\/.%0A"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139855952.091"},{"issue":"1","key":"e_1_2_8_84_1","first-page":"95","article-title":"Hepatotoxicity of paracetamol and related fatalities","volume":"21","author":"Tittarelli R","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_8_85_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209264"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1611593"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102240"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264\u2010020\u201000953\u20100"},{"key":"e_1_2_8_89_1","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.11.20061994"},{"key":"e_1_2_8_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110982"},{"key":"e_1_2_8_91_1","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2021.1951239"},{"key":"e_1_2_8_92_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102020\u2010217871"},{"key":"e_1_2_8_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13119"},{"key":"e_1_2_8_94_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102020\u2010219517"},{"key":"e_1_2_8_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264\u2010021\u201001089\u20105"},{"key":"e_1_2_8_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1949"},{"key":"e_1_2_8_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15512"},{"key":"e_1_2_8_98_1","unstructured":"WHO.The use of non\u2010steroidal anti\u2010inflammatory drugs (NSAIDs) in patients with COVID\u201019. Published 2020. Accessed2022.https:\/\/www.who.int\/news\u2010room\/commentaries\/detail\/the\u2010use\u2010of\u2010non\u2010steroidal\u2010anti\u2010inflammatory\u2010drugs\u2010(nsaids)\u2010in\u2010patients\u2010with\u2010covid\u201019"},{"key":"e_1_2_8_99_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.18501120"},{"key":"e_1_2_8_100_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12048"},{"key":"e_1_2_8_101_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323000203000311"},{"key":"e_1_2_8_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27412"},{"key":"e_1_2_8_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7119.1333"},{"key":"e_1_2_8_104_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344\u2010200605001\u201000003"},{"key":"e_1_2_8_105_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1011278107"},{"key":"e_1_2_8_106_1","unstructured":"EMA.EuropeanMedicines Agency Updated Advice on Use of High\u2010Dose Ibuprofen 2015. Published 2015. Accessed2022.https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/ibuprofen\u2010dexibuprofen\u2010containing\u2010medicines"},{"key":"e_1_2_8_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.07.006"},{"key":"e_1_2_8_108_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.10.6878"},{"key":"e_1_2_8_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296\u2010019\u201004332\u20106"},{"key":"e_1_2_8_110_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574886312666170616090640"},{"key":"e_1_2_8_111_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199427060-00005"},{"key":"e_1_2_8_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2011.01313.x"},{"key":"e_1_2_8_113_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198530010-00004"},{"key":"e_1_2_8_114_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182412936"},{"issue":"7","key":"e_1_2_8_115_1","first-page":"1061","article-title":"Adverse drug reactions and drug \u2013 drug interactions with over\u2010the\u2010counter NSAIDs","volume":"11","author":"Moore N","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"e_1_2_8_116_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103646"},{"key":"e_1_2_8_117_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c00352"},{"key":"e_1_2_8_118_1","unstructured":"AIFA.AgenziaItaliana del Farmaco Ibuprofene\u2010Riassunto delle caratteristiche del prodotto. Published 2022. Accessed October 6 2022.https:\/\/farmaci.agenziafarmaco.gov.it\/aifa\/servlet\/PdfDownloadServlet?pdfFileName=footer_008043_042324_RCP.pdf&sys=m0b1l3"},{"issue":"3","key":"e_1_2_8_119_1","first-page":"269","article-title":"The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non\u2010steroidal anti\u2010inflammatory drug (NSAID), in man","volume":"48","author":"Busch U","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"e_1_2_8_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2510050106"},{"key":"e_1_2_8_121_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/27.2.209"},{"key":"e_1_2_8_122_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707259"},{"key":"e_1_2_8_123_1","doi-asserted-by":"publisher","DOI":"10.1211\/0022357001774507"},{"key":"e_1_2_8_124_1","article-title":"Which NSAIDs are Most Selective for COX\u20101 and COX\u20102?","author":"Behnen Timpe","journal-title":"Pract Pain Manag"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.2258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T12:22:09Z","timestamp":1694089329000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/jcph.2258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":123,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1002\/jcph.2258"],"URL":"https:\/\/doi.org\/10.1002\/jcph.2258","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"assertion":[{"value":"2023-03-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}